Hikma Pharmaceuticals Share Discussion Threads

[broadwood] 17/3/2015 16:20

Middle East focused Hikma Pharmaceuticals is reportedly planning to sell its first benchmark-sized dollar bonds, according to two people familiar with the sale.
Bloomberg News on Tuesday cited sources close to the deal in its report. Shares in Hikma fell 1.8% to 2217p on the back of the report, as market participants sought to ascertain the driver behind the company's need to raise capital.

Analysts think it may have to do with recent news over the FTSE Group announcing at its quarterly reshuffle that Hikma will be promoted into the UK's FTSE 100 Index of London leading shares on March 24. The stock is currently located in the FTSE 250 Index together with a listing in NASDAQ Dubai.

Hikma was founded in Jordan in 1978 and develops and manufactures a range of branded and non-branded drugs for US and European markets but with a focus on the Middle East and North Africa.

According to Bloomberg's report, Hikma has selected Barclays, Citigroup, HSBC and National Bank of Abu Dhabi to manage the sale of its first benchmark bond which may have a tenor of five years, say sources.

Benchmark-sized bonds tend to raise at least $500m when issued in the market. Bond issuances in the Middle East and North Africa rose 78% to $9.3bn this year, according to data compiled by Bloomberg, as issuers flood the market before the Federal Reserve starts its rate hiking measure, expected this year.

According to Bloomberg, Hikma, Barclays, Citigroup and National Bank of Abu Dhabi all declined to comment and a spokesman for HSBC couldn't immediately be reached

[pyemckay] 05/3/2015 17:01

This is very highly rated now and there is no room for any misses on growth or earnings.
Forward p/e 27. I am looking for an aquisition soon as forecast growth isnt as strong as I would like.


I still hold but will re-evalute very soon.

[karateboy] 03/3/2015 17:23

From my experience, share price prior to being upgraded to Ftse 100 always goes up on institutional investors taking a position. Following confirmation , share price settles down until good news come along. I believe that is just what is happening.

[mikemartin83] 03/3/2015 15:25

Any ideas on why the big drop today?

[rosieoutlook] 01/3/2015 22:19

In today's Sunday Telegraph: Hikma Pharmaceuticals, the Jordanian drug maker, is expected to take the place of Tullow Oil in Britain’s benchmark share index at this week’s quarterly review of FTSE indices

[coppertrader] 26/2/2015 18:44

Hikma Pharmaceuticals, a leading multinational pharmaceutical group, has signed an exclusive license agreement with specialty pharmaceutical company Azanta for its proprietary cancer product Nimoral (nimorazole). Nimoral is a hypoxic radiosensitiser that will enhance the effect of radiotherapy in head and neck cancer patients, said a statement.The product is currently in Phase 3 clinical development and is being made available under named patient programmes throughout the world, it said.Under the terms of the agreement, Hikma will have the exclusive rights to register, manufacture, distribute and market Nimoral in 20 markets in the Middle East and North Africa (Mena) region including Turkey, leveraging Hikma's strong local presence and regulatory expertise, with over 1,800 sales and marketing reps across the region.Mazen Darwazah, Hikma's vice chairman and chief executive of Mena and Emerging Markets, said: "Hikma is committed to improving the treatment of cancer in the Mena region through the development of our oncology product portfolio. "This partnership gives us access to a novel, oral anticancer treatment with excellent potential and reinforces our commitment to growing our portfolio through strong partnerships. We look forward to the Phase 3 results for Nimoral and we are very pleased to be working with Azanta to bring this critically needed therapy to the Mena region."Dr. Claus Møller, chief executive officer of Azanta, said: "We are very pleased to enter this significant agreement with Hikma. We believe Hikma will be an excellent partner for us for Nimoral in the Mena region, which has a population of more than 380 million people or six per cent of the world population." - TradeArabia News Service

[coppertrader] 13/2/2015 13:02

FTSE Quarterly ReviewMeetings to review the constituents of the FTSE100 and FTSE Mid-250 are held on the Wednesday after the first Friday in March, June, September and December. Any constituent changes are then implemented on the next trading day following the expiry of the LIFFE futures and options contracts, which normally takes place on the third Friday of the same month. Promotion/Demotion decisions are based on the companies' relative market capitalisation at the close of business on the Tuesday prior to the Quarterly Review Meeting. The rules the Committee will apply are as follows:

[johnthespacer] 13/2/2015 09:55

When would promotion happen do you think - is the a particular time each month?

[coppertrader] 13/2/2015 08:31

Hik are bouncing around 77th position in the ftse table. Promotion to the ftse100 is very likely with the exception of the share price plumetting.

[karateboy] 11/2/2015 20:13

I guess £24 is becoming support not a resistance ...

[lateralam] 10/2/2015 08:22

Anyone tell me why the big drop yesterday please? Been away for a few days.

[karateboy] 01/2/2015 10:11

Morrison market cap is now £400m less than HIK. So HIK should join Ftsee 100 in the next shuffle...

[karateboy] 30/1/2015 19:01

Who is Myland? But I agree any possible bid should be around £40. Let's hope for that.

[stats11] 29/1/2015 17:55

hxxp://www.fiercepharma.com/story/mylan-said-be-eyeing-7b-plus-bid-rising-star-hikma/2015-01-28

[stats11] 29/1/2015 17:53

wouldn’t be surprised!

[liam1om] 28/1/2015 09:22

Bid speculation today 3900 mentioned from Mylan.

[karateboy] 19/1/2015 18:25

Good day for HIK today. Analysts are expected to upgrade the share if HIK wins its court case in USA which she has now...apostrophe corrected. Thanks

[trewsa] 19/1/2015 09:46

The RSI hit 80-overbought after 10 days going up.
Don't need apostrophe in its.No idea.

[karateboy] 18/1/2015 20:11

HIK shares dropped a bit last few days. I wonder that was due to MRW market cap is being stabilised after the the result. MRW may stay in Ftse. The other issue may be HIK governance. Its chairman and chief executive is the same man. I believe as a condition to enter Ftse 100, these 2 posts should be kept separate...any comments?